QIAGEN (QGEN)
(Delayed Data from NYSE)
$41.52 USD
-0.37 (-0.88%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $41.52 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth D Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 27% (78 out of 251)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.89 | 1.35 | 9.99 |
Current Quarter Estimate | 0.44 | 7.43 | 60.00 |
Year Ago Quarter Estimate | 0.53 | 0.12 | 52.54 |
Next Quarter Estimate | 0.52 | 7.81 | 61.00 |
Next Year Estimate | 2.26 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 0.97 | 12.90 | 17.08 |
Next Year | 8.13 | 7.90 | 8.00 |
Last 5 Years | 8.30 | 1.00 | 8.10 |
Next 5 Years | 5.70 | 20.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 19.79 | -2.18 |
Price/Book (MRQ) | 2.51 | 2.01 |
Price/Cash Flow (MRFY) | 13.42 | 14.08 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 17.37% | -100.99% |
Return on Equity (TTM) | 12.99% | -55.59% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.